Corrigendum to "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer" [Cancer Lett. 532 (2022) 215588].
APA
Feng S, Huang Q, et al. (2026). Corrigendum to "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer" [Cancer Lett. 532 (2022) 215588].. Cancer letters, 639, 218251. https://doi.org/10.1016/j.canlet.2026.218251
MLA
Feng S, et al.. "Corrigendum to "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer" [Cancer Lett. 532 (2022) 215588].." Cancer letters, vol. 639, 2026, pp. 218251.
PMID
41539871
같은 제1저자의 인용 많은 논문 (5)
- Nanozyme for precision treatment of hepatocellular carcinoma.
- Wave-Aware Weakly Supervised Histopathological Tissue Segmentation With Cross-Scale Logits Distillation.
- MicroRNA-15a-5p suppresses triple-negative breast cancer cell proliferation and invasion by modulating T-cell immunoreceptor associated with immunoglobulin and ITIM domain expression.
- Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer.
- Overview of immune checkpoint inhibitor associated myocarditis mechanisms diagnostics and treatment.